ASH Annual Meeting 2023 - Full Playlist

At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. This podcast series features exclusive conversations on breaking data for novel therapies, technological innovations in hematology/oncology, efforts to reduce disparities and improve health equity, and more!

Advancing Inclusion for Blood Donation Systems for Marginalized Groups: Warren Fingrut, MD

Lowering Talquetamab Dosing Intensity to Improve Tolerability: Ajai Chari, MD

Addressing Ethical Concerns Around Artificial Intelligence in Cancer Care: Andrew Hantel, MD

Expanding Access to Brexucabtagene Autoleucel for Mantle Cell Lymphoma: Andre Goy, MD

Reducing Stigmatizing Language in the EMR for More Equitable Care: Alex Boucher, MD

At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on patient advocacy groups in hematology, efforts to reduce racial disparities in multiple myeloma clinical trials, real-world outcomes of novel agents in the community setting, and much more!

CLL Society: Paving the Way For CLL Patients and Survivors With Brian Koffman, MD

Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care is an accredited, two-part series led by expert Yelena Y. Janjigian, MD. 

Building on the foundation of biomarker-driven care, this module focuses on optimizing treatment strategies for patients with esophagogastric cancer. Dr. Janjigian reviews the latest evidence on targeted therapies, immunotherapies, and combination regimens, as well as practical considerations for sequencing and selecting therapies. Gain actionable insights to enhance collaborative care and deliver the most effective, individualized treatment plans for your patients. Listen now!

Click here to claim credit for this activity: https://bit.ly/3HtOziO

Click here to listen to Module 1 of this series: https://bit.ly/45u106o

Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care Module 2

Click here to view the full article on Oncology Data Advisor: https://oncdata.com-ai-ascomind 

ASCOmind is a novel artificial intelligence (AI) framework designed to help clinicians, researchers, and industry teams synthesize the vast amount of data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting. In the latest episode of Exploring AI in Oncology, Waqas Haque, MD, MPH, speaks with Xiaoyan Wang, PhD, Research Professor at Tulane University, and William Oh, MD, Professor of Internal Medicine at Yale School of Medicine, about the development, integration, and benefits of this valuable tool. 

From Abstracts to Action: How ASCOmind Streamlines Oncology Insights With Xiaoyan Wang, PhD; William Oh, MD; and Waqas Haque, MD, MPH

Extrapulmonary neuroendocrine carcinomas (EP-NECs) are rare, aggressive tumors that present unique diagnostic and treatment challenges. In this accredited activity podcast, leading experts Dr. Andrew E. Hendifar and Dr. Danielle Hutchings from Cedars-Sinai Medical Center share practical strategies and emerging evidence on diagnosis, current therapies, and novel treatment targets.

Listen now to gain actionable insights and stay current on evolving approaches in EP-NECs!

Click the link to claim your CE credit: https://bit.ly/488fPhK

Clinical Challenges in Extrapulmonary NEC: Expert Insights on Diagnosis, Treatment, and Emerging Targets

Extrapulmonary neuroendocrine carcinomas (EP-NECs) are rare, aggressive tumors that present unique diagnostic and treatment challenges. In this accredited activity podcast, leading experts Dr. Andrew E. Hendifar and Dr. Danielle Hutchings from Cedars-Sinai Medical Center share practical strategies and emerging evidence on diagnosis, current therapies, and novel treatment targets.

Listen now to gain actionable insights and stay current on evolving approaches in EP-NECs!

Click the link to claim your CE credit:

Transform your approach to CLL care with insights from clinical pharmacy expert, "Kelsey Marciano, PharmD, BCOP,UCHealth. This podcast unpacks the latest strategies for treatment selection and toxicity management—empowering oncology pharmacists to lead confidently, maximize patient outcomes, and deliver next-level care in the evolving era of oral targeted therapies.

🎧 Listen now and click the link to claim your CE credit!

Claim your credit here: https://bit.ly/4pGrLO5

🔗 Learn more and access continuing education activities: https://i3health.com

📲 Stay connected with i3 Health:

Twitter/X: https://bit.ly/42VAYs1
LinkedIn: https://bit.ly/3IMiCmv
Facebook: https://bit.ly/46JrQI2
YouTube: https://bit.ly/4pNhWxR
Instagram: https://bit.ly/4nUSNzE
Threads: https://bit.ly/3Wd6oq9

🎧 Subscribe to the i3 Health Podcast on your favorite streaming platform so you never miss the latest expert discussions!

Optimizing CLL Care: Pharmacist-Led Strategies for Treatment Selection and Toxicity Management

Transform your approach to CLL care with insights from clinical pharmacy expert, "Kelsey Marciano, PharmD, BCOP,UCHealth. This podcast unpacks the latest strategies for treatment selection and toxicity management—empowering oncology pharmacists to lead confidently, maximize patient outcomes, and deliver next-level care in the evolving era of oral targeted therapies.

🎧 Listen now and click the link to claim your CE credit!

Claim your credit here: bit.ly/4pGrLO5

🔗 Learn more and access continuing education activities: i3health.com

📲 Stay connected with i3 Health:

Twitter/X: https://bit.ly/3ITDaJV
Facebook: https://bit.ly/46wmwJo
YouTube: https://bit.ly/46PXLXx

🎧 Subscribe to the Oncology Data Advisor Podcast on your favorite streaming platform so you never miss the latest expert discussions!

Read the full article at: https://oncdata.com/travis-osterman-ai-informatics 

In this episode of Exploring AI in Oncology, Dr. Waqas Haque speaks with Dr. Travis Osterman, Director of Cancer Clinical Informatics at Vanderbilt-Ingram Cancer Center, about the evolving role of health informatics in oncology. Their conversation spans training pathways, precision oncology, data standards, AI integrations, and the strategies to promote adoption in both academic and community practices.

Charting New Paths in Oncology Informatics With Travis Osterman, DO, and Waqas Haque, MD, MPH

Psoriatic arthritis care is rapidly evolving, demanding multidisciplinary collaboration and timely access to evidence-based therapies for optimal patient outcomes. i3 Health's Multidisciplinary Task Force—Increasing Early Intervention and Optimizing Management in Psoriatic Arthritis—convened expert clinicians and a patient moderator to address real-world challenges in screening, diagnosis, comorbidity management, and therapeutic optimization.

In this follow-up interview, Archie Franklin, MBA, a psoriatic arthritis patient and Task Force moderator, shares insights on the discussion, the changing treatment landscape, and practical guidance for elevating standards of care.

Click here to view the Task Force and claim your CE credit: https://bit.ly/4h5NSKb

Additional Insights in Psoriatic Arthritis With Archie Franklin, MBA

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

CLL Society: Paving the Way For CLL Patients and Survivors With Brian Koffman, MD

Oncology Data Advisor®

Related tracks